Wu Gong (Scolopendra subspinipes) Pharmacology — The ‘Chinese Red-Headed Centipede’ Behind Da Huo Luo Dan, Stubborn-Headache Powders, and Modern Kv2.1 Analgesic Peptide Research

If Quan Xie is the polite older brother of Chinese animal drugs — small, pale, salted, almost demure once dried — then Wu Gong (蜈蚣) is the brother nobody invites to dinner. Open the paper bag a Cantonese herbalist hands you and twenty desiccated, fifteen-centimetre Chinese red-headed centipedes spill onto the counter, jaws hooked into bamboo splints, dorsal plates shining a faint iridescent blue-green over rust-red heads and ochre legs. They look, frankly, alarming. They are also, by classical reckoning, one of the most potent anti-spasmodic and pain-unblocking drugs in the entire Materia Medica — and modern peptide pharmacology has begun to spell out, residue by residue, why.

Wu Gong rarely appears in Western medicated oils, and almost never in alcohol-based dit-da liniments meant for transdermal use, because — as with Quan Xie — its active peptides do not cross intact stratum corneum efficiently. But it sits inside many of the oral companion pills that Chinese clinicians dispense alongside topical liniments: Da Huo Luo Dan (大活络丹), Xiao Huo Luo Dan (小活络丹) in some regional variants, Zai Zao Wan (再造丸), Zhi Jing San (止痉散, the canonical scorpion-plus-centipede powder), Qian Zheng San (牵正散) for facial palsy in some modern adaptations, and a long tail of trigeminal-neuralgia and stubborn-migraine prescriptions written in Lingnan and northern Chinese clinics.

This article unpacks what is actually doing the work inside that bamboo-splinted carcass: the venom and tissue chemistry, the modern ion-channel pharmacology, the formulas Wu Gong anchors, and the safety lines that every serious user — clinician or patient — has to know cold.

1. Zoology, provenance, and processing

The official medicinal centipede in the Chinese Pharmacopoeia is Scolopendra subspinipes mutilans L. Koch, family Scolopendridae — the Chinese red-headed centipede. It is a sub-tropical to warm-temperate species, twelve to twenty centimetres long when adult, easily recognised by its rust-red head and tail, twenty-one pairs of yellow-orange legs, and dark green-brown to blue-black dorsal plates. It is not the same as the giant Amazonian or Vietnamese forest centipedes that occasionally appear on social media, although those belong to the same genus and share much of the venom chemistry.

Medicinally graded supply comes from Hubei (the historic Shashi-Jingzhou belt), Hunan, Henan, Anhui, Jiangsu, and Zhejiang, with Hubei’s Jingzhou prefecture still considered the gold-standard origin (荆州蜈蚣, Jīngzhōu wú gōng). Wild populations have collapsed under decades of pharmaceutical demand, and most pharmacy-grade material now comes from regulated farms, where the centipedes are reared on cricket and mealworm diets in stacked clay-tile shelters and harvested in their second or third spring, when the body length and venom yield peak.

The classical processing protocol is critical and very different from Quan Xie’s brine bath:

Live centipedes are starved for forty-eight hours to clear the gut.
Each animal is stretched and pinned head-to-tail onto a thin bamboo splint (竹片), jaws and tail straightened, then quickly killed by either drowning in boiling water or, in some northern workshops, by a brief flash in a low oven.
They are dried in shade until the body is rigid and the bamboo splint can be removed, leaving the characteristic flat, ribbon-shaped final product.

The bamboo-splint step is not cosmetic. A curled, unpinned centipede dries into a brittle spiral that fragments on shipping and concentrates broken legs and venom-gland fluid unevenly between batches. The flattened, splinted form gives quality controllers a chance to verify that the head, jaws (顎肢, the venom-bearing first pair of legs called forcipules), and tail are all intact — three classical markers of authentic, unadulterated material. Pharmacopoeial assays now also require a centipede-specific peptide HPLC fingerprint, since powdered Wu Gong has historically been a target for adulteration with other arthropods.

Most clinical formulas use the whole dried animal ground to a fine powder. Decoction is generally avoided: heat denatures many of the peptides that do the analgesic and anti-convulsant work, and the standard administration route is oral powder, 0.6–1 g per dose, swallowed with warm water or wrapped into pill matrices alongside other herbs.

2. Chemistry — what is actually inside that centipede

Wu Gong is a chemical category-buster. Unlike most TCM “single herbs,” it is biologically two drugs in one carrier:

Venom-derived peptides and proteins, concentrated in the forcipule glands but distributed throughout the body in trace amounts after killing.
Whole-body tissue compounds — alkaloids, fatty acids, polysaccharide-protein complexes, free amino acids, and trace minerals — that survive drying and grinding and are extractable in aqueous, ethanolic, or oily preparations.

Modern mass-spectrometry and transcriptomics work, especially the 2020s scoping reviews of S. subspinipes, has resolved at least four pharmacologically distinct fractions:

Peptide neurotoxins including SsmTX-I, a potent and selective Kv2.1 voltage-gated potassium channel blocker, and several Nav (voltage-gated sodium channel) modulators in the related Scolopendra-toxin (SsTx) family. These peptides — typically 3–6 kDa, disulfide-rich, structurally analogous to scorpion and spider toxin scaffolds — explain most of the modern analgesic literature.
Histamine-like and serotonin-like biogenic amines, responsible for the immediate burning and oedema of a fresh centipede bite, but largely degraded in properly dried material.
Phospholipase A2 (PLA2) and various proteases, contributing to the local anti-inflammatory paradox: they are pro-inflammatory in fresh venom but, in fractionated and orally administered extracts, appear to down-regulate downstream NF-κB and MAPK signalling in chronic inflammation models.
Polysaccharide-protein complexes with documented anti-tumour and immunomodulatory activity in murine sarcoma and hepatoma models — the basis of the experimental oncology literature that has grown around Wu Gong since the 1990s.
Whole-body alkaloids and quinoline derivatives with reported antimicrobial and antifungal effects, particularly against dermatophytes — the pharmacological footing under classical topical use of centipede-infused oils for ringworm and stubborn skin sores.

The single most-discussed compound in the contemporary literature is SsmTX-I. In rodent models of inflammatory and neuropathic pain it has produced analgesic effects comparable or superior to morphine, without the respiratory depression, tolerance, or reward-circuit activation of opioid drugs. Mechanistically it works upstream of the opioid system entirely, by selectively blocking Kv2.1 channels on dorsal root ganglion neurons and damping the repolarisation that allows pain fibres to fire repetitively. Several non-opioid analgesic programmes — both Chinese-academy and Western biotech — are now tracking this scaffold as a candidate for chronic pain drug development.

3. Classical pharmacology and indications

In classical Chinese medical texts (Shen Nong Ben Cao Jing, Bencao Gangmu) Wu Gong is 辛, 温, 有毒 — pungent, warm, toxic — and enters the Liver (肝) channel. Its three classical actions are:

息风止痉 (Xī fēng zhǐ jìng) — extinguish wind, stop spasm. Used for tetanus, infantile convulsions, epilepsy, post-stroke contractures, and trigeminal neuralgia presenting as “wind in the channels.”
通络止痛 (Tōng luò zhǐ tòng) — unblock the collaterals, stop pain. Used for stubborn headaches, joint pain, post-traumatic pain, and intractable rheumatic pain that has failed simpler interventions.
攻毒散结 (Gōng dú sàn jié) — attack toxin, disperse nodules. Used topically and orally for snake bite, mastitis, scrofula, and certain skin sores; this is the indication that has been extended in modern oncology research.

The single most-cited classical pairing is the 三虫 (sān chóng — “three insects”) combination of 全蝎 (Quan Xie / scorpion), 蜈蚣 (Wu Gong / centipede), and 僵蚕 (Jiang Can / silkworm), ground to powder and taken in warm water for obstinate, treatment-resistant headache, trigeminal neuralgia, and migraine variants. This formula, sometimes formalised as Zhi Jing San (止痉散) when only Quan Xie and Wu Gong are used, remains in widespread clinical use across mainland China and Taiwan, and is the most common context in which a Western clinician will first encounter prescribed Wu Gong.

4. Formulations Wu Gong sits inside

Wu Gong is rarely a stand-alone agent. It travels in formulas. The most clinically relevant include:

Da Huo Luo Dan (大活络丹) — the great collateral-unblocking pill, a fifty-plus-ingredient formula for post-stroke hemiplegia, advanced rheumatoid pain, and chronic spastic conditions. Wu Gong here pairs with Quan Xie, Wu Shao She (烏梢蛇) or Bai Hua She (白花蛇), and processed Aconite to handle deep, fixed pain that has resisted gentler pills.
Zai Zao Wan (再造丸) — the “rebuilding pill” for post-stroke recovery, structurally similar to Da Huo Luo Dan but with adjusted toxic-herb ratios and a stronger blood-moving emphasis.
Zhi Jing San (止痉散) — the canonical Quan Xie + Wu Gong powder for migraine, trigeminal neuralgia, and post-herpetic neuralgia, dosed at 0.6–1.5 g of mixed powder, twice daily.
Modified Qian Zheng San (牵正散加味) — for facial nerve palsy and post-Bell’s-palsy spasm, where Wu Gong is added to the classical Bai Fu Zi / Bai Jiang Can / Quan Xie skeleton when the spasm component is prominent.
Topical centipede-infused oils and tinctures — much rarer than the oral pills, these are typically dit-da preparations made by macerating dried Wu Gong in high-proof alcohol or sesame oil for several weeks, then applying to non-broken skin for tinea, stubborn boils, scorpion stings, and some traditionalists’ anti-rheumatic plasters. Transdermal delivery of the major peptides is poor, so the topical activity is thought to be driven mostly by the alkaloid and quinoline fractions.

5. Modern pharmacology — what the lab work has confirmed

Across the published preclinical record, Wu Gong shows:

Anti-convulsant activity — water and ethanolic extracts raise seizure threshold and shorten seizure duration in pentylenetetrazole and electroshock rodent models, and the effect is potentiated when combined with Quan Xie extracts. This corresponds to the classical “extinguish wind, stop spasm” indication and is the basis for Wu Gong’s continued use in adjunctive epilepsy and post-stroke spasticity protocols in China.
Analgesia, both inflammatory and neuropathic — driven primarily by Kv2.1-blocking peptides such as SsmTX-I, with comparable efficacy to morphine in formalin and chronic constriction injury models, and without opioid tolerance development on repeat dosing.
Cardiovascular effects — water-soluble, deproteinised whole-body extracts produce dose-dependent vasodilation, modest blood-pressure lowering, and a positive inotropic effect on isolated atrium preparations. This is mechanistically distinct from the peptide analgesia and likely sits behind the classical use in stroke recovery formulas.
Antimicrobial and antifungal activity — particularly against dermatophytes such as Trichophyton mentagrophytes and Microsporum canis, providing a pharmacological footing for traditional topical use against tinea and stubborn skin sores.
Antithrombotic and fibrinolytic activity — Wu Gong fibrinolytic enzymes show dose-dependent clot lysis in vitro, of interest in stroke-recovery and cerebrovascular research.
Antitumour activity — polysaccharide-protein complexes inhibit growth of S180 sarcoma, H22 hepatoma, and several human cancer cell lines in vitro and in xenograft models, by inducing apoptosis and modulating RhoA-pathway signalling. This work is preclinical but actively pursued in Chinese-academy oncology programmes.
Neuroprotection — extracts attenuate β-amyloid-induced neuronal damage and reduce oxidative stress markers in Alzheimer’s-related cell-culture models, contributing to a small but persistent line of research on animal-drug neuroprotectives.

The therapeutic gap between the dried, ground centipede a herbalist dispenses and a purified Kv2.1-blocking peptide drug is large, and clinicians should not pretend it is small. But the pharmacological direction of travel is consistent with classical use to a degree that is unusual in animal-drug research.

6. Safety, dose, and adulteration

Wu Gong is classified as toxic in the Chinese Pharmacopoeia. The dose envelope is narrow and non-negotiable:

Adult oral dose: 0.6–1 g of dried powder per day, divided into two or three doses, typically inside a multi-herb pill or capsule. Decoction doses run higher (3–5 g) but extract less of the heat-labile peptide fraction.
Pediatric and elderly doses are reduced by one-third to one-half, and Wu Gong is generally avoided in children under three.
Pregnancy is an absolute contraindication. Wu Gong is uterotonic in animal models and classified as abortifacient in classical texts.
Hepatic and renal impairment — relative contraindications, since the alkaloid fraction undergoes hepatic metabolism and the peptide fraction renal clearance.
Allergy to arthropods, shellfish, or other invertebrate proteins — relative contraindication; centipede tropomyosins cross-react with shrimp and dust-mite allergens in case reports.

The acute toxicity picture in overdose is dominated by nausea, vomiting, sweating, palpitations, and — in severe cases — haemolysis, hepatic enzyme elevation, and acute renal injury from the haemolytic protein and PLA2 fractions. Reports of significant toxicity almost always involve home-made tinctures, mis-dosed pediatric administration, or counterfeit products containing unrelated arthropods.

Adulteration is a real and ongoing concern. Powdered Wu Gong has historically been cut with other dried arthropods (yellow centipedes of unrelated species, dried millipedes, ground beetle wing-cases), and in some cheap commercial pill preparations the “Wu Gong” content may be primarily filler. Buyers should insist on whole, splinted, head-and-tail-intact specimens for visual inspection, and clinicians ordering powdered material should request the centipede-specific peptide HPLC fingerprint that pharmacopoeial-grade suppliers can provide.

7. Where Wu Gong fits in the medicated-oil ecosystem

Wu Gong is not, and should not be marketed as, a transdermal active. Its place in the broader medicated-oil ecosystem is as the oral pharmacological partner to the topical liniments, dit-da oils, and salves that Chinese, Hong Kong, Taiwanese, and Southeast Asian families keep in the cabinet. A dit-da oil moves blood and warms surface channels; a Wu Gong-containing pill, prescribed alongside, addresses the deeper, central, spastic, or neuropathic component of the same complaint. Reading a classical Lingnan post-stroke or trigeminal-neuralgia protocol without understanding this oral-topical pairing is reading half the prescription.

For a Western reader meeting Wu Gong for the first time, three takeaways matter most. First, the centipede in the paper bag is a prescription-grade pharmacological agent, not a folk curiosity, and the Pharmacopoeia takes its dosing seriously. Second, the modern peptide work — particularly on Kv2.1-blocking analgesic peptides — points toward a non-opioid pain pharmacology that classical clinicians have been navigating empirically for fifteen hundred years. Third, the safety boundary is real, narrow, and enforced by pregnancy, pediatric, and allergy contraindications that no thoughtful clinician should soft-pedal.

The drug is alarming on the counter and gentle, in proper hands, on the patient. The reverse, in untrained hands, is also exactly true.